Epstein.Interpretación de biopsias de la próstata, 6ed

 INTERPRETACIÓN DE BIOPSIAS DE LA PRÓSTATA

208

20. Sebo TJ, Bock BJ, Cheville JC, et al.The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol . 2000; 163(1):174–178. 21. Conrad S, Graefen M, Pichlmeier U, et al. Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma. J Urol . 2002;167(2, pt 1):521–525. 22. Karram S, Trock BJ, Netto GJ, et al. Should intervening benign tissue be included in the measure- ment of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatec- tomy findings. Am J Surg Pathol . 2011;35(9):1351–1355. 23. Arias-Stella JA III, Varma KR, Montoya-Cerrillo D, et al. Does discontinuous involvement of a prostatic needle biopsy core by adenocarcinoma correlate with a large tumor focus at radical prosta- tectomy? Am J Surg Pathol . 2015;39(2):281–286. 24. Schultz L, Maluf CE, da Silva RC, et al. Discontinuous foci of cancer in a single core of prostatic biopsy: when it occurs and performance of quantification methods in a private-practice setting. Am J Surg Pathol . 2013;37(12):1831–1836. 25. Fontugne J, Davis K, Palanisamy N, et al. Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry. Mod Pathol . 2016;29(2):157–165. 26. Freedland SJ,Terris MK, Csathy GS, et al. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. J Urol . 2004;171(6, pt 1):2215–2220. 27. Grossfeld GD, Latini DM, Lubeck DP, et al. Predicting disease recurrence in intermediate and high-­ risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology . 2002;59(4):560–565. 28. Nelson CP, Rubin MA, Strawderman M, et al. Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy. Urology . 2002;59(5):740–745, discussion 745–746. 29. Quinn DI, Henshall SM, Brenner PC, et al. Prognostic significance of preoperative factors in locali- zed prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Cancer . 2003;97(8):1884–1893. 30. Kestin LL, Goldstein NS, Vicini FA, et al. Percentage of positive biopsy cores as predictor of clinical out- come in prostate cancer treated with radiotherapy. J Urol . 2002;168(5):1994–1999. 31. Lieberfarb ME, Schultz D,Whittington R, et al. Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy. Int J Radiat Oncol Biol Phys . 2002;53(4):898–903. 32. Merrick GS, Butler WM, Wallner KE, et al. Prognostic significance of percent positive biopsies in clinically organ-confined prostate cancer treated with permanent prostate brachytherapy with or wi- thout supplemental external-beam radiation. Cancer J . 2004;10(1):54–60. 33. Rossi PJ, Clark PE, Papagikos MA, et al. Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer. Urology . 2006;67(2):349–353. 34. Wong WW, Schild SE, Vora SA, et al. Association of percent positive prostate biopsies and perineu- ral invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys . 2004;60(1):24–29. 35. Cupp MR, Bostwick DG, Myers RP, et al. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol . 1995;153(5):1543–1548. 36. Lewis JS Jr, Vollmer RT, Humphrey PA. Carcinoma extent in prostate needle biopsy tissue in the prediction of whole gland tumor volume in a screening population. Am J Clin Pathol . 2002; 118(3):442–450. 37. Noguchi M, Stamey TA, McNeal JE, et al. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol . 2001;166(1):104–109, discussion 109–110. SAMPLE